VEGFA and diabetes mellitus: Moreover, systemic treatment or different medications used for treating DM could have an impact on CT in these patients. VEGF is an important cytokine that mediates vascular hyper-permeability, so an increase in VEGF levels, which is expected in an advanced stage of DR and DME, can affect CT in these patients.